hs-CRP Blood Test: High-Sensitivity CRP & Heart Risk

The high-sensitivity CRP test (hs-CRP) does not measure a different protein from ordinary CRP: it measures the exact same molecule — C-reactive protein — but with a more sensitive assay that can read very low levels. Its job is not to catch an infection — for that, see our CRP blood test guide — but to gauge the low-grade inflammation of atherosclerosis as part of cardiovascular risk assessment. This guide explains what hs-CRP measures, the risk bands (<1, 1–3, >3 mg/L), why a value above 10 mg/L is not interpreted as heart risk, and what the test actually adds. hs-CRP is one piece of the cardiac blood tests picture.

Key takeaways

• hs-CRP measures the same protein as standard CRP, but a high-sensitivity assay reads low levels (down to ~0.2 mg/L) that the ordinary test can't distinguish.¹²
• It reflects chronic low-grade inflammation involved in atherosclerosis — so it is a cardiovascular risk marker, not an infection test.²³
• Cardiovascular risk bands (AHA/CDC, mg/L): <1 = low risk, 1–3 = average risk, >3 = high risk.¹
• A value above 10 mg/L is NOT interpreted as heart risk: it signals acute infection or inflammation, and the test should be repeated later (≥2 weeks), once you're back to baseline.¹²
• It mainly refines risk when it's intermediate and can help a statin decision; it is a risk-modifying factor, not a stand-alone treatment target, and it does not replace the lipid panel.⁴²
• hs-CRP is not a cancer marker and needs no fasting: it's the same molecule as CRP — only the use is different.⁵

What is high-sensitivity CRP?

C-reactive protein (CRP) is an inflammation protein made by the liver. During an infection or acute inflammation it rises sharply (tens to hundreds of mg/L) — the classic use covered in our CRP blood test guide. But we now know that atherosclerosis — plaque building up in the arteries — carries a chronic, very low-grade inflammation that nudges CRP up only slightly, into a range (often <3 mg/L) where the standard assay isn't precise enough.²³

The high-sensitivity CRP test solves that. It is not a different protein or a "new" CRP: it's the same molecule, measured with a more sensitive method calibrated to read low values reliably (roughly 0.2 to 10 mg/L). That precision lets clinicians sort people by their background inflammation and estimate part of their cardiovascular risk.¹²

hs-CRP is CRP. The key point: it is the same protein. What changes is the precision of the assay and, above all, the purpose: ordinary CRP hunts for an infection or inflammation, while hs-CRP gauges cardiovascular risk. One blood draw, two different questions.

Why the test is done

Your clinician may order hs-CRP to fine-tune your cardiovascular risk estimate, on top of the usual factors (age, blood pressure, smoking, diabetes, cholesterol).²⁶ It is most useful when the calculated risk is intermediate: a high hs-CRP may then tip toward more active management (for example starting a statin), while a low value is reassuring.⁴²

In practice it comes in addition to the lipid panel — total cholesterol, LDL, apolipoprotein B — which it never replaces: lipids and inflammation are two complementary dimensions of risk.³ It is not a blanket screening test for the whole population, and its value depends on context — your clinician decides whether it's useful in your situation.⁶²

Do you need to fast?

No. Like standard CRP, hs-CRP needs no fasting and can be drawn at any time.⁵ What matters is measuring it away from an acute event: an infection, a recent vaccination, a flare of inflammation, surgery, or an injury will push CRP up and distort the cardiovascular interpretation. Ideally, hs-CRP is measured when you are metabolically stable, and often repeated (two readings a couple of weeks apart, then averaged).¹² If your draw includes other tests (glucose, lipid panel), it's those that may require fasting — see Do you need to fast before a blood test?.

Normal ranges and risk bands

Unlike most markers, hs-CRP isn't read as "normal vs. abnormal" but in cardiovascular risk bands. The reference cut-offs come from a joint statement of the American Heart Association (AHA) and the CDC: they are risk categories, to be interpreted by your clinician for your profile, and values can vary by lab and assay.¹

Units: hs-CRP is reported in mg/L, the same as standard CRP (no conversion). A value above 10 mg/L is not read as "very high cardiovascular risk": it almost always reflects a transient acute inflammation (infection, injury, flare). In that case, draw no heart conclusion and repeat the test once you're back to baseline (at least 2 weeks later).¹²

Understanding your results

High hs-CRP

An hs-CRP in the 1–3 mg/L (average risk) or >3 mg/L (high risk) band points to more low-grade inflammation, statistically associated with a higher rate of cardiovascular events (heart attack, stroke).¹³ It is not a diagnosis: it's one input your clinician folds in with the rest — total cholesterol, LDL, apolipoprotein B, blood pressure, smoking, diabetes, family history. Many non-cardiac factors also raise hs-CRP (see below), which is why it's read away from acute illness and often on two readings.¹

The key point: a high hs-CRP is a risk-modifying, associated factor, not a treatment target in itself. The goal isn't to "lower the number" for its own sake; it's to estimate overall risk better and decide on management (lifestyle, lipid control, sometimes a statin).⁴² It does not replace the lipid panel — lipids and inflammation give complementary information.³

hs-CRP and cancer? A high hs-CRP is not a tumor marker and screens for no cancer. It reflects the background inflammation of your arteries and body, not a tumor. A frankly high value (>10 mg/L) mostly signals ordinary acute inflammation to be rechecked.

Low hs-CRP

An hs-CRP below 1 mg/L is reassuring: it reflects low background inflammation and a lower cardiovascular risk (all else equal).¹ It needs no treatment and signals no problem — for this marker, a low value is good news.

The inflammation–cholesterol duo

hs-CRP makes most sense next to cholesterol. A collaborative analysis of over 31,000 statin-treated patients (the PROMINENT, REDUCE-IT, and STRENGTH trials) found that, in people already on a statin, hs-CRP predicted events and death at least as well as — arguably better than — LDL: the concept of residual inflammatory risk that persists despite good lipid control.³ Inflammation and cholesterol are read together, not one against the other.

What affects your hs-CRP

Many things move hs-CRP, which is why it must be drawn when you're well: any infection, recent vaccination, surgery, injury, or inflammatory flare (arthritis, autoimmune disease) raises it — sometimes >10 mg/L — and makes the cardiovascular reading impossible at that moment.¹² It also runs higher with overweight/obesity, smoking, diabetes, or metabolic syndrome, and shifts with age. Conversely, physical activity, quitting smoking, weight loss, and statins tend to lower it. Tell your clinician about any recent infection or inflammatory illness — it's decisive for reading the result.

Recent research

According to recent PubMed-indexed publications:

• JUPITER: the original proof. The JUPITER trial enrolled people with normal LDL but hs-CRP ≥ 2 mg/L: rosuvastatin cut heart attacks, strokes, and deaths, showing that a high hs-CRP flags people who benefit from treatment even without high cholesterol.⁴ (Ridker PM et al., N Engl J Med, 2008 — DOI.)
• CANTOS: inflammation as a cause, not just a bystander. The CANTOS trial tested canakinumab, an anti-interleukin-1β antibody (ChEMBL CHEMBL1201834) with no effect on lipids: it reduced cardiovascular events, the first proof that acting directly on inflammation protects the heart.⁷⁸
• Colchicine: COLCOT and LoDoCo2. Two large trials — COLCOT (after a heart attack) and LoDoCo2 (chronic coronary disease) — showed that low-dose colchicine, an old anti-inflammatory (ChEMBL CHEMBL107, now marketed for cardiovascular risk), lowers events, confirming the value of targeting residual inflammation.⁹¹⁰⁸
• A concept now endorsed. The 2025 ACC Scientific Statement from the American College of Cardiology establishes the role of low-grade inflammation and hs-CRP in cardiovascular risk assessment and prevention, while cautioning that not all anti-inflammatory strategies have proven effective: hs-CRP helps stratify risk — it does not, by itself, dictate treatment.²³ (Mensah GA et al., J Am Coll Cardiol, 2025 — DOI.)

These findings concern diagnosis and research; they do not authorize self-medication and do not replace your physician's advice.

Get your hs-CRP interpreted by AI DiagMe

An hs-CRP is never read alone: its meaning depends on your total cholesterol, your LDL, your apolipoprotein B, your blood pressure, your smoking status, and your context — and it only counts away from an infection. That cross-reading is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

Bottom line

The hs-CRP blood test measures the same protein as CRP, just more finely and for a different question: gauging the low-grade inflammation of atherosclerosis to stratify cardiovascular risk. Keep the bands in mind (<1 low, 1–3 average, >3 high mg/L), remember that a value above 10 mg/L is not interpreted (acute inflammation → repeat later), and that it must be measured away from acute illness, ideally on two readings. It's a risk-modifying factor, not a stand-alone treatment target, and it does not replace the lipid panel. It's not a cancer marker, and needs no fasting. No value is read alone — it's your whole set of markers and your context that counts, which is what AI DiagMe provides, alongside your physician.

Sources

Official sources and peer-reviewed publications (PubMed, ChEMBL) used for this guide: